# Filing Detail

Form SC 13E3 - Going private transaction by certain issuers:
SEC Accession No. 0001213900-25-115118
Filing Date
2025-11-26
Accepted
2025-11-26 09:17:17
Documents
37
Group Members
CRYSTAL PEAK HOLDINGS INC.CRYSTAL PEAK INVESTMENT INC.DAVE LIGUANG CHENNHUAQIN XUEOCEANPINE CAPITAL INC.OCEANPINE INVESTMENT FUND II LPOCEANPINE MERGER SUB INC.OCEANPINE SKYLINE INC.

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | SCHEDULE 13E-3 | ea0266906-sc13e3_lake.htm | SC 13E3 | 220156
2 | PRELIMINARY PROXY STATEMENT OF THE COMPANY DATED NOVEMBER [ ], 2025 (THE "PROXY | ea026690601ex99-a1_lake.htm | EX-99.(A)(1) | 1704596
3 | DISCUSSION MATERIALS PREPARED BY DUFF & PHELPS FOR DISCUSSION WITH THE SPECIAL C | ea026690601ex99-c2_lake.htm | EX-99.(C)(2) | 46788
4 | CALCULATION OF FILING FEE TABLES | ea026690601ex-fee_lake.htm iXBRL | EX-FILING FEES | 11963
5 | GRAPHIC | exa-1_001.jpg | GRAPHIC | 4009
6 | GRAPHIC | exa-1_002.jpg | GRAPHIC | 3232
7 | GRAPHIC | exc-2_001.jpg | GRAPHIC | 286930
8 | GRAPHIC | exc-2_002.jpg | GRAPHIC | 896823
9 | GRAPHIC | exc-2_003.jpg | GRAPHIC | 143092
10 | GRAPHIC | exc-2_004.jpg | GRAPHIC | 149583
11 | GRAPHIC | exc-2_005.jpg | GRAPHIC | 732609
12 | GRAPHIC | exc-2_006.jpg | GRAPHIC | 569077
13 | GRAPHIC | exc-2_007.jpg | GRAPHIC | 317207
14 | GRAPHIC | exc-2_008.jpg | GRAPHIC | 390840
15 | GRAPHIC | exc-2_009.jpg | GRAPHIC | 600983
16 | GRAPHIC | exc-2_010.jpg | GRAPHIC | 371730
17 | GRAPHIC | exc-2_011.jpg | GRAPHIC | 382276
18 | GRAPHIC | exc-2_012.jpg | GRAPHIC | 106341
19 | GRAPHIC | exc-2_013.jpg | GRAPHIC | 525039
20 | GRAPHIC | exc-2_014.jpg | GRAPHIC | 493086
21 | GRAPHIC | exc-2_015.jpg | GRAPHIC | 477020
22 | GRAPHIC | exc-2_016.jpg | GRAPHIC | 599007
23 | GRAPHIC | exc-2_017.jpg | GRAPHIC | 386067
24 | GRAPHIC | exc-2_018.jpg | GRAPHIC | 344897
25 | GRAPHIC | exc-2_019.jpg | GRAPHIC | 405559
26 | GRAPHIC | exc-2_020.jpg | GRAPHIC | 360812
27 | GRAPHIC | exc-2_021.jpg | GRAPHIC | 232639
| Complete submission text file | 0001213900-25-115118.txt |  | 14192743

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
39 | EXTRACTED XBRL INSTANCE DOCUMENT | ea026690601ex-fee_lake_htm.xml | XML | 4743

Mailing Address BUILDING NO. 2, 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK DAXING DISTRICT, BEIJING F4 102629
Business Address BUILDING NO. 2, 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK DAXING DISTRICT, BEIJING F4 102629 17327133678
LakeShore Biopharma Co., Ltd. (Filed by) CIK: 0001946399 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: SC 13E3
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address BUILDING NO. 2, 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK DAXING DISTRICT, BEIJING F4 102629
Business Address BUILDING NO. 2, 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK DAXING DISTRICT, BEIJING F4 102629 17327133678
LakeShore Biopharma Co., Ltd. (Subject) CIK: 0001946399 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: SC 13E3 | Act: 34 | File No.: 005-94412 | Film No.: 251524941
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)